NCT00602498View on ClinicalTrials.gov

Bioequivalency Study of Clarithromycin Tablets Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Infection
Interventions
DRUG

Clarithromycin

Trial Locations (1)

85044-5318

MDS Pharma Services, Phoenix

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00602498 - Bioequivalency Study of Clarithromycin Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter